Patients with poorly differentiated tumors undergoing liver transplantation comprise a heterogeneous group of patients with different prognoses.
α-Fetoprotein concentration and tumor size can predict outcomes in patients with G3 tumors before liver transplantation.
A group of patients with acceptable survival can be selected from among patients with poorly differentiated hepatocellular carcinoma treated with liver transplantation.